| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
NL:AGN
Aegon NV
|
May 29, 2026 | HOLD |
Buy
-8.7% avg upside
11 analysts
|
$7.05
4.46% Downside
|
· |
|
CH:SLHN
Swiss Life Holding AG
|
May 20, 2026 | SELL |
Hold
-8.3% avg upside
4 analysts
|
$850.00
2.06% Downside
|
· |
|
GB:MNG
M&G Plc
|
May 05, 2026 | HOLD |
Buy
-10.2% avg upside
13 analysts
|
$300.00
8.07% Downside
|
· |
|
GB:PRU
Prudential
|
Apr 27, 2026 | BUY |
Strong Buy
+859.9% avg upside
22 analysts
|
$1470.00
46.26% Upside
|
· |
|
GB:SDLF
Standard Life plc
|
Apr 20, 2026 | BUY |
Buy
-2.2% avg upside
12 analysts
|
$870.00
8.33% Upside
|
· |
|
CH:HBAN
Helvetia Holding AG
|
Apr 09, 2026 | BUY |
Sell
-19.0% avg upside
3 analysts
|
$225.00
9.48% Upside
|
· |
|
GB:LGEN
Legal & General
|
Mar 20, 2026 | HOLD |
Buy
+554.4% avg upside
15 analysts
|
$250.00
11.73% Downside
|
· |
|
GB:AV
Aviva plc
|
Mar 11, 2026 | BUY |
Buy
+2.8% avg upside
14 analysts
|
$750.00
19.97% Upside
|
· |
|
NL:ASRNL
ASR Nederland N.V
|
Feb 24, 2026 | HOLD |
Strong Buy
+0.4% avg upside
9 analysts
|
$66.50
1.93% Upside
|
· |
|
GB:STJ
St. James's Place
|
Feb 20, 2026 | BUY |
Buy
+401.9% avg upside
16 analysts
|
$1465.00
28.83% Upside
|
· |
|
GB:0Q99
ageas NV
|
Jan 20, 2026 | HOLD |
Buy
-11.8% avg upside
7 analysts
|
$61.00
9.32% Downside
|
· |
|
NL:NN
NN Group N.V.
|
Aug 12, 2025 | HOLD |
Buy
-14.7% avg upside
11 analysts
|
$66.30
10.62% Downside
|
· |
|
DE:MUV2
Munich Reinsurance
|
Dec 07, 2023 | HOLD |
Buy
-0.1% avg upside
14 analysts
|
— | · |
|
DE:ALV
Allianz
|
Dec 07, 2023 | BUY |
Buy
-10.3% avg upside
21 analysts
|
— | · |
|
AEG
Aegon
|
Jan 12, 2023 | BUY |
Buy
-42.2% avg upside
7 analysts
|
— | +21.1% |
|
FR:CS
AXA SA
|
Oct 11, 2021 | HOLD |
Strong Buy
+4.4% avg upside
17 analysts
|
— | · |
|
IT:G
Assicurazioni Generali S.p.A.
|
Oct 11, 2021 | HOLD |
Buy
-15.4% avg upside
15 analysts
|
— | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.